M&A Deal Summary

EVER Neuro Pharma Acquires Amneal Deutschland

On May 17, 2019, EVER Neuro Pharma acquired life science company Amneal Deutschland from Amneal Pharmaceuticals

Acquisition Highlights
  • This is EVER Neuro Pharma’s 1st transaction in the Life Science sector.
  • This is EVER Neuro Pharma’s 1st transaction in Germany.

M&A Deal Summary

Date 2019-05-17
Target Amneal Deutschland
Sector Life Science
Buyer(s) EVER Neuro Pharma
Sellers(s) Amneal Pharmaceuticals
Deal Type Divestiture

Target

Amneal Deutschland

Gröbenzell, Germany
Amneal Deutschland GmbH is a manufacturer and distributor of pharmaceuticals products. Amneal Deutschland GmbH is based in Gröbenzell, Germany.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

EVER Neuro Pharma

Unterach, Austria

Category Company
Founded 1934
Sector Life Science
DESCRIPTION

EVER Neuro Pharma GmbH is a fully integrated specialty pharmaceutical company focused on the research, development, production, and commercialization of products in the areas of neurology, critical care, anesthesia and oncology. EVER Neuro Pharma GmbH was founded in 1934 and is based in Unterach, Austria.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2019 M&A 1 of 1

Seller(S) 1

SELLER

Amneal Pharmaceuticals

Bridgewater, New Jersey, United States

Category Company
Founded 2002
Sector Healthcare Services
Employees8,300
Revenue 2.8B USD (2024)
DESCRIPTION

Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was founded in 2002 and is based in Bridgewater, New Jersey.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
Country: Germany M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-07 Gemini Laboratories

Bridgewater, New Jersey, United States

Gemini Laboratories LLC is specialty pharmaceutical company provides a prescription products in various therapeutic areas. Gemini Laboratories was founded in 2013 and is based in Bridgewater, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-10 R&S Northeas

Pulaski, Tennessee, United States

AvKARE, Inc. is a licensed manufacturer and wholesaler of pharmaceuticals products. AvKARE serves the Department of Defense, Veterans Hospitals, NASA, TriCare, Dept. of Agriculture, Indian Health Services, USDA, U.S. Army, Air Force, Navy, and USMC, as well as Group Purchasing Organizations that include Amerinet, Innovatix, Health Trust Purchasing Group, IPC, Broadlane/MedAssets and Premier. AvKARE is based in Pulaski, Tennessee.

Buy $340M